Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Analysis of novel hyperosmotic shock response suggests 'beads in liquid' cytosol structure.

Alexandrov AI, Grosfeld EV, Dergalev AA, Kushnirov VV, Chuprov-Netochin RN, Tyurin-Kuzmin PA, Kireev II, Ter-Avanesyan MD, Leonov SV, Agaphonov MO.

Biol Open. 2019 Jul 10;8(7). pii: bio044529. doi: 10.1242/bio.044529.

2.

Yeast Sup35 Prion Structure: Two Types, Four Parts, Many Variants.

Dergalev AA, Alexandrov AI, Ivannikov RI, Ter-Avanesyan MD, Kushnirov VV.

Int J Mol Sci. 2019 May 29;20(11). pii: E2633. doi: 10.3390/ijms20112633.

3.

Increasing throughput of manual microscopy of cell suspensions using solid medium pads.

Alexandrov AI, Dergalev AA.

MethodsX. 2019 Feb 15;6:329-332. doi: 10.1016/j.mex.2019.02.010. eCollection 2019.

4.

Protein synthesis and quality control in aging.

Anisimova AS, Alexandrov AI, Makarova NE, Gladyshev VN, Dmitriev SE.

Aging (Albany NY). 2018 Dec 18;10(12):4269-4288. doi: 10.18632/aging.101721.

5.

First-in-Human Phase I Study of MBC-11, a Novel Bone-Targeted Cytarabine-Etidronate Conjugate in Patients with Cancer-Induced Bone Disease.

Zinnen SP, Karpeisky A, Von Hoff DD, Plekhova L, Alexandrov A.

Oncologist. 2019 Mar;24(3):303-e102. doi: 10.1634/theoncologist.2018-0707. Epub 2018 Nov 9.

6.

High-Reynolds Microfluidic Sorting of Large Yeast Populations.

Keinan E, Abraham AC, Cohen A, Alexandrov AI, Mintz R, Cohen M, Reichmann D, Kaganovich D, Nahmias Y.

Sci Rep. 2018 Sep 13;8(1):13739. doi: 10.1038/s41598-018-31726-6.

7.

Distinct mechanisms of mutant huntingtin toxicity in different yeast strains.

Serpionov GV, Alexandrov AI, Ter-Avanesyan MD.

FEMS Yeast Res. 2017 Jan;17(1). pii: fow102. doi: 10.1093/femsyr/fow102. Epub 2016 Dec 2.

PMID:
27915242
8.

First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B.

Blank A, Markert C, Hohmann N, Carls A, Mikus G, Lehr T, Alexandrov A, Haag M, Schwab M, Urban S, Haefeli WE.

J Hepatol. 2016 Sep;65(3):483-9. doi: 10.1016/j.jhep.2016.04.013. Epub 2016 Apr 27.

PMID:
27132172
9.

Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study.

Bogomolov P, Alexandrov A, Voronkova N, Macievich M, Kokina K, Petrachenkova M, Lehr T, Lempp FA, Wedemeyer H, Haag M, Schwab M, Haefeli WE, Blank A, Urban S.

J Hepatol. 2016 Sep;65(3):490-8. doi: 10.1016/j.jhep.2016.04.016. Epub 2016 Apr 27.

PMID:
27132170
10.

A protein polymerization cascade mediates toxicity of non-pathological human huntingtin in yeast.

Serpionov GV, Alexandrov AI, Antonenko YN, Ter-Avanesyan MD.

Sci Rep. 2015 Dec 17;5:18407. doi: 10.1038/srep18407.

11.

Quantitative bile acid profiling by liquid chromatography quadrupole time-of-flight mass spectrometry: monitoring hepatitis B therapy by a novel Na(+)-taurocholate cotransporting polypeptide inhibitor.

Haag M, Hofmann U, Mürdter TE, Heinkele G, Leuthold P, Blank A, Haefeli WE, Alexandrov A, Urban S, Schwab M.

Anal Bioanal Chem. 2015 Sep;407(22):6815-25. doi: 10.1007/s00216-015-8853-5. Epub 2015 Jul 5.

PMID:
26143062
12.

Extremely high-power CO2 laser beam correction.

Kudryashov A, Alexandrov A, Rukosuev A, Samarkin V, Galarneau P, Turbide S, Châteauneuf F.

Appl Opt. 2015 May 10;54(14):4352-8. doi: 10.1364/AO.54.004352.

PMID:
25967488
13.

Proteomic screening for amyloid proteins.

Nizhnikov AA, Alexandrov AI, Ryzhova TA, Mitkevich OV, Dergalev AA, Ter-Avanesyan MD, Galkin AP.

PLoS One. 2014 Dec 30;9(12):e116003. doi: 10.1371/journal.pone.0116003. eCollection 2014.

14.

Self-excising integrative yeast plasmid vectors containing an intronated recombinase gene.

Agaphonov M, Alexandrov A.

FEMS Yeast Res. 2014 Nov;14(7):1048-54. doi: 10.1111/1567-1364.12197. Epub 2014 Sep 5.

15.

Range-wide genetic structure of maritime pine predates the last glacial maximum: evidence from nuclear DNA.

Naydenov KD, Alexandrov A, Matevski V, Vasilevski K, Naydenov MK, Gyuleva V, Carcaillet C, Wahid N, Kamary S.

Hereditas. 2014 Feb;151(1):1-13. doi: 10.1111/j.1601-5223.2013.00027.x. Epub 2014 Mar 13.

16.

Prevention of cerebral embolization by placing a neuroprotection filter before recoarctation stent dilation.

Vassilev DI, Rigatelli G, Kaneva-Nencheva A, Levunlieva E, Alexandrov A.

JACC Cardiovasc Interv. 2014 Feb;7(2):e11-e12. doi: 10.1016/j.jcin.2013.05.030. Epub 2014 Jan 15. No abstract available.

17.

Stenting below-the-knee bifurcations with dedicated bifurcation stent BiOSS Lim - first in man case report.

Vassilev D, Mateev H, Alexandrov A, Stankev M, Rigatelli G, Gil RJ.

Cardiovasc Revasc Med. 2014 Apr;15(3):171-7. doi: 10.1016/j.carrev.2013.09.005. Epub 2013 Oct 22.

PMID:
24157310
18.

Could yeast prion domains originate from polyQ/N tracts?

Alexandrov AI, Ter-Avanesyan MD.

Prion. 2013 May-Jun;7(3):209-14. doi: 10.4161/pri.24628.

19.

Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts.

Schieck A, Schulze A, Gähler C, Müller T, Haberkorn U, Alexandrov A, Urban S, Mier W.

Hepatology. 2013 Jul;58(1):43-53. doi: 10.1002/hep.26211. Epub 2013 May 15.

PMID:
23292963
20.

The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus.

Volz T, Allweiss L, Ben MBarek M, Warlich M, Lohse AW, Pollok JM, Alexandrov A, Urban S, Petersen J, Lütgehetmann M, Dandri M.

J Hepatol. 2013 May;58(5):861-7. doi: 10.1016/j.jhep.2012.12.008. Epub 2012 Dec 13.

PMID:
23246506

Supplemental Content

Loading ...
Support Center